Impact of breastfeeding beyond 12 months on HIV transmission, mortality and morbidity among HIV-exposed uninfected infants in sub-Saharan Africa: a protocol for a systematic review and meta-analysis
Résumé
Introduction Globally, over 1.1 million HIV-exposed uninfected (HEU) infants are born annually, predominantly in sub-Saharan Africa (SSA). Despite effective prevention of mother-to-child transmission programmes, HEU infants face disproportionately higher risks of malnutrition, morbidity and mortality compared with HIV-unexposed peers. Uncertainty remains about the optimal duration of breastfeeding in this population. Most SSA national guidelines recommend cessation at 12 months, yet emerging evidence suggests that early cessation may increase malnutrition and mortality risk, particularly in resource-limited settings. No recent systematic review has comprehensively synthesised evidence on the effects of extended breastfeeding beyond 12 months on key health outcomes among HEU infants. Methods and analysis This systematic review will include randomised controlled trials (RCTs), quasi-RCTs and prospective and retrospective cohort studies comparing health outcomes in HEU infants breastfed beyond 12 months versus those breastfed for 12 months or less. Electronic databases to be searched include MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cumulative Index to Nursing and Allied Health Literature, Latin American and Caribbean Health Sciences Literature, African Index Medicus and Web of Science, from 1 January 2013 to 31 December 2025. Two independent reviewers will screen studies, extract data and assess risk of bias using the Cochrane Risk of Bias tool and the Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) tools. The primary outcome is the incidence of postnatal HIV transmission. Secondary outcomes include all-cause infant mortality, nutritional status (stunting, wasting, underweight) and morbidity (pneumonia and diarrhoea). Both pairwise and network meta-analyses will be conducted using random-effects models. Evidence certainty will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Ethics and dissemination This study is a systematic review and meta-analysis of previously published studies and does not involve collection of new data from human participants. As such, ethical approval from an Institutional Review Board or Ethics Committee was not required. Findings will be disseminated through a peer-reviewed publication, conference presentations, policy briefs and stakeholder engagement with national and international health authorities including the Wolrd Health Organization (WHO) and the United Nations Programme on HIV/AIDS (UNAIDS). PROSPERO registration number CRD420251150712.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 09/11/2026. Le document reste hébergé par sa source.
Voir le document à la source →